Compugen | CGEN - Ativos





Ativos Alterar Data
Arca Biopharma USD 504.48M 15.86M 2026-03
aTyr Pharma USD 69.82M 9.83M 2026-06
Bio Path USD 677K 13K 2026-03
Brainstorm Cell Therapeutics USD 755K 267K 2026-03
Cara Therapeutics USD 25.82M 6.26M 2026-03
Clal Biotechnology ILS 158.39M 24.3M 2023-12
Compugen USD 145.86M 10.71M 2026-03
Immunic USD 189.74M 165.69M 2026-03
Minerva Neurosciences USD 97.97M 69.88M 2025-12
RedHill Biopharma USD 25.34M 6.97M 2025-12
TherapeuticsMD USD 40.13M 1.96M 2024-06